Donald Trump & Moderna

Donald Trump: Donald Trump>>>'s administration has been criticized for cuts to foreign aid and withdrawal from the World Health Organization>>>, which experts say have weakened global health response capabilities, though he has expressed concern about the outbreak and pledged some funding.

Moderna: Moderna is one of the entities developing an experimental vaccine for the Bundibugyo virus, which could lead to future revenue and enhance its reputation in vaccine development.

Donald Trump: The Trump administration imposed a temporary ban on entry for non-US passport holders who visited Congo, Uganda, or South Sudan, and plans to send exposed Americans to a new facility in Kenya.

Moderna: Moderna is utilizing its mRNA technology to develop a vaccine for the Bundibugyo strain of Ebola, with funding from CEPI, aiming to rapidly train the body to fight the virus.

Donald Trump: Donald Trump>>>'s administration's past decision to withdraw from the World Health Organization>>> and cut foreign aid was criticized for weakening surveillance systems.

Moderna: Moderna is a key partner in the urgent high-level coordination meeting convened by United States — Centers for Disease Control and Prevention, potentially involved in assessing medical countermeasures for the Ebola outbreak.

Moderna: Moderna, a manufacturer of widely used COVID-19 vaccines, did not immediately comment on the new policy.

Moderna: Moderna had $766 million in funding for its mRNA-1018 vaccine canceled by the United States — United States Department of Health and Human Services, adding uncertainty to the vaccine's development.